The administration is associating acetaminophen or Tylenol used during pregnancy with a possible increased risk of autism based on earlier studies. As a result, The FDA will issue a physician notice and start the process to change safety labeling for acetaminophen to reflect these concerns. Now, the administration is also launching a public service campaign to inform families and advise pregnant women to use acetaminophen only when medically necessary. (04:33–04:42)
CLAIM
Asserts that the FDA will change safety labeling for acetaminophen due to autism risk concerns.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
